BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16265693)

  • 21. Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus.
    Ugarte-Gil MF; Dubey J; McGwin G; Reveille JD; Vilá LM; Alarcón GS
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):585-589. PubMed ID: 35255194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort.
    Fernández M; Alarcón GS; McGwin G; Sanchez ML; Apte M; Vilá LM; Reveille JD;
    Arthritis Rheum; 2007 Aug; 57(6):986-92. PubMed ID: 17665468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage.
    Toloza SM; Roseman JM; Alarcón GS; McGwin G; Uribe AG; Fessler BJ; Bastian HM; Vilá LM; Reveille JD
    Arthritis Rheum; 2004 Oct; 50(10):3177-86. PubMed ID: 15476246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and prognostic value of autoantibodies in puerto Ricans with systemic lupus erythematosus.
    Vilá LM; Molina MJ; Mayor AM; Peredo RA; Santaella ML; Vilá S
    Lupus; 2006; 15(12):892-8. PubMed ID: 17211998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.
    Durán S; Apte M; Alarcón GS; Marion MC; Edberg JC; Kimberly RP; Zhang J; Langefeld CD; Vilá LM; Reveille JD;
    Arthritis Rheum; 2008 Sep; 59(9):1332-40. PubMed ID: 18759263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity.
    Alarcón GS; McGwin G; Sanchez ML; Bastian HM; Fessler BJ; Friedman AW; Baethge BA; Roseman J; Reveille JD
    Arthritis Rheum; 2004 Feb; 51(1):73-7. PubMed ID: 14872458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus in a multiethnic US Cohort LUMINA XLVIII: factors predictive of pulmonary damage.
    Bertoli AM; Vila LM; Apte M; Fessler BJ; Bastian HM; Reveille JD; Alarcon GS;
    Lupus; 2007; 16(6):410-7. PubMed ID: 17664231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
    Zen M; Iaccarino L; Gatto M; Saccon F; Larosa M; Ghirardello A; Punzi L; Doria A
    Ann Rheum Dis; 2018 Jan; 77(1):104-110. PubMed ID: 28970217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.
    Burgos PI; Alarcón GS; McGwin G; Crews KQ; Reveille JD; Vilá LM
    Arthritis Rheum; 2009 Sep; 61(9):1179-86. PubMed ID: 19714612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].
    Chaiamnuay S; Bertoli AM; Fernández M; Apte M; Vilá LM; Reveille JD; Alarcón GS;
    J Clin Rheumatol; 2007 Jun; 13(3):128-33. PubMed ID: 17551377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture.
    Alarcón GS; Roseman J; Bartolucci AA; Friedman AW; Moulds JM; Goel N; Straaton KV; Reveille JD
    Arthritis Rheum; 1998 Jul; 41(7):1173-80. PubMed ID: 9663472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.
    Pons-Estel GJ; Alarcón GS; González LA; Zhang J; Vilá LM; Reveille JD; McGwin G;
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):393-400. PubMed ID: 20391486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and
    Zaminski D; Saxena A; Izmirly P; Buyon JP; Belmont HM
    Lupus Sci Med; 2023 Nov; 10(2):. PubMed ID: 37963669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.
    Alarcón GS; Calvo-Alén J; McGwin G; Uribe AG; Toloza SM; Roseman JM; Fernández M; Fessler BJ; Vilá LM; Ahn C; Tan FK; Reveille JD;
    Ann Rheum Dis; 2006 Sep; 65(9):1168-74. PubMed ID: 16905579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
    Bruce IN; O'Keeffe AG; Farewell V; Hanly JG; Manzi S; Su L; Gladman DD; Bae SC; Sanchez-Guerrero J; Romero-Diaz J; Gordon C; Wallace DJ; Clarke AE; Bernatsky S; Ginzler EM; Isenberg DA; Rahman A; Merrill JT; Alarcón GS; Fessler BJ; Fortin PR; Petri M; Steinsson K; Dooley MA; Khamashta MA; Ramsey-Goldman R; Zoma AA; Sturfelt GK; Nived O; Aranow C; Mackay M; Ramos-Casals M; van Vollenhoven RF; Kalunian KC; Ruiz-Irastorza G; Lim S; Kamen DL; Peschken CA; Inanc M; Urowitz MB
    Ann Rheum Dis; 2015 Sep; 74(9):1706-13. PubMed ID: 24834926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria.
    Bastian HM; Alarcón GS; Roseman JM; McGwin G; Vilá LM; Fessler BJ; Reveille JD;
    Rheumatology (Oxford); 2007 Apr; 46(4):683-9. PubMed ID: 17132694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral vascular damage in systemic lupus erythematosus: data from LUMINA, a large multi-ethnic U.S. cohort (LXIX).
    Burgos PI; Vilá LM; Reveille JD; Alarcón GS
    Lupus; 2009 Dec; 18(14):1303-8. PubMed ID: 19850658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Damage accrual in systemic lupus erythematosus in Dominicans in New York City and the Dominican Republic.
    Geraldino-Pardilla L; Kapoor T; Canto I; Perez-Recio T; Then J; Tineo C; Loyo E; Askanase A
    Lupus; 2018 Oct; 27(12):1989-1995. PubMed ID: 30092732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory.
    Alarcón GS; Cianfrini L; Bradley LA; Sanchez ML; Brooks K; Friedman AW; Baethge BA; Fessler BJ; Bastian HM; Roseman JM; McGwin G; Reveille JD;
    Arthritis Rheum; 2002 Jun; 47(3):310-9. PubMed ID: 12115162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.